These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 20033712)

  • 1. Comparison of endoscopic ultrasonography (EUS), positron emission tomography (PET), and computed tomography (CT) in the preoperative locoregional staging of resectable esophageal cancer.
    Choi J; Kim SG; Kim JS; Jung HC; Song IS
    Surg Endosc; 2010 Jun; 24(6):1380-6. PubMed ID: 20033712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role and clinical value of EUS in a multimodality esophageal carcinoma staging program with CT and positron emission tomography.
    Pfau PR; Perlman SB; Stanko P; Frick TJ; Gopal DV; Said A; Zhang Z; Weigel T
    Gastrointest Endosc; 2007 Mar; 65(3):377-84. PubMed ID: 17321235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study between endoscopic ultrasonography and positron emission tomography-computed tomography in staging patients with esophageal squamous cell carcinoma.
    Yen TJ; Chung CS; Wu YW; Yen RF; Cheng MF; Lee JM; Hsu CH; Chang YL; Wang HP
    Dis Esophagus; 2012 Jan; 25(1):40-7. PubMed ID: 21595776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implication of PET/MR imaging in preoperative esophageal cancer staging: comparison with PET/CT, endoscopic ultrasonography, and CT.
    Lee G; I H; Kim SJ; Jeong YJ; Kim IJ; Pak K; Park DY; Kim GH
    J Nucl Med; 2014 Aug; 55(8):1242-7. PubMed ID: 24868109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is positron emission tomography useful in locoregional staging of esophageal cancer? Results of a multidisciplinary initiative comparing CT, positron emission tomography, and EUS.
    Sandha GS; Severin D; Postema E; McEwan A; Stewart K
    Gastrointest Endosc; 2008 Mar; 67(3):402-9. PubMed ID: 18178202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy.
    Cerfolio RJ; Bryant AS; Ohja B; Bartolucci AA; Eloubeidi MA
    J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1232-41. PubMed ID: 15942562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy of preoperative staging for a priori resectable esophageal cancer.
    Winiker M; Mantziari S; Figueiredo SG; Demartines N; Allemann P; Schäfer M
    Dis Esophagus; 2018 Jan; 31(1):1-6. PubMed ID: 29346598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoscopic ultrasonography in esophageal cancer leads to improved survival rates: results from a population-based study.
    Wani S; Das A; Rastogi A; Drahos J; Ricker W; Parsons R; Bansal A; Yen R; Hosford L; Jankowski M; Sharma P; Cook MB
    Cancer; 2015 Jan; 121(2):194-201. PubMed ID: 25236485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic ultrasound staging for early esophageal cancer: Are we denying patients neoadjuvant chemo-radiation?
    Luu C; Amaral M; Klapman J; Harris C; Almhanna K; Hoffe S; Frakes J; Pimiento JM; Fontaine JP
    World J Gastroenterol; 2017 Dec; 23(46):8193-8199. PubMed ID: 29290655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of EUS in Determining Curative Resectability in Reference to CT and FDG-PET: The Optimal Sequence in Preoperative Staging of Esophageal Cancer?
    Schreurs LM; Janssens AC; Groen H; Fockens P; van Dullemen HM; van Berge Henegouwen MI; Sloof GW; Pruim J; van Lanschot JJ; Steyerberg EW; Plukker JT
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):1021-1028. PubMed ID: 21547703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of fluorodeoxyglucose-positron emission tomography (FDG-PET) and endoscopic ultrasonography parameters in predicting survival following surgery for esophageal cancer.
    Omloo JM; Sloof GW; Boellaard R; Hoekstra OS; Jager PL; van Dullemen HM; Fockens P; Plukker JT; van Lanschot JJ
    Endoscopy; 2008 Jun; 40(6):464-71. PubMed ID: 18543134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymph node staging in esophageal squamous cell carcinoma: a comparative study of endoscopic ultrasonography versus computed tomography.
    Takizawa K; Matsuda T; Kozu T; Eguchi T; Kato H; Nakanishi Y; Hijikata A; Saito D
    J Gastroenterol Hepatol; 2009 Oct; 24(10):1687-91. PubMed ID: 19788609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective analysis of the diagnostic accuracy of 3 T MRI, CT and endoscopic ultrasound for preoperative T staging of potentially resectable esophageal cancer.
    Guo J; Wang Z; Qin J; Zhang H; Liu W; Zhao Y; Lu Y; Yan X; Zhang Z; Zhang T; Zhang S; Dominik NM; Kamel IR; Li H; Qu J
    Cancer Imaging; 2020 Sep; 20(1):64. PubMed ID: 32912319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Appraisal of staging endoscopic ultrasonography in a modern high-volume esophageal program.
    O'Farrell NJ; Malik V; Donohoe CL; Johnston C; Muldoon C; Reynolds JV; O'Toole D
    World J Surg; 2013 Jul; 37(7):1666-72. PubMed ID: 23568244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective comparison of MR with diffusion-weighted imaging, endoscopic ultrasound, MDCT and positron emission tomography-CT in the pre-operative staging of oesophageal cancer: results from a pilot study.
    Giganti F; Ambrosi A; Petrone MC; Canevari C; Chiari D; Salerno A; Arcidiacono PG; Nicoletti R; Albarello L; Mazza E; Gallivanone F; Gianolli L; Orsenigo E; Esposito A; Staudacher C; Del Maschio A; De Cobelli F
    Br J Radiol; 2016 Dec; 89(1068):20160087. PubMed ID: 27767330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low impact of staging EUS for determining surgical resectability in esophageal cancer.
    van Zoonen M; van Oijen MG; van Leeuwen MS; van Hillegersberg R; Siersema PD; Vleggaar FP
    Surg Endosc; 2012 Oct; 26(10):2828-34. PubMed ID: 22692460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenocarcinoma of the esophagus and the esophagogastric junction: positron emission tomography improves staging and prediction of survival in distant but not in locoregional disease.
    Sihvo EI; Räsänen JV; Knuuti MJ; Minn HR; Luostarinen ME; Viljanen T; Färkkilä MA; Salo JA
    J Gastrointest Surg; 2004 Dec; 8(8):988-96. PubMed ID: 15585386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple staging investigations may not change management in patients with high-grade dysplasia or early esophageal adenocarcinoma.
    Reyhani A; Gimson E; Baker C; Kelly M; Maisey N; Meenan J; Subesinghe M; Hill M; Lagergren J; Gossage J; Zeki S; Dunn J; Davies A
    Dis Esophagus; 2023 Sep; 36(10):. PubMed ID: 37032121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgically resected T1- and T2-stage esophageal squamous cell carcinoma: T and N staging performance of EUS and PET/CT.
    Jeong DY; Kim MY; Lee KS; Choi JY; Kim SJ; Chung MJ; Min YW; Kim HK; Zo JI; Shim YM; Sun JM
    Cancer Med; 2018 Aug; 7(8):3561-3570. PubMed ID: 29932307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer.
    Swisher SG; Maish M; Erasmus JJ; Correa AM; Ajani JA; Bresalier R; Komaki R; Macapinlac H; Munden RF; Putnam JB; Rice D; Smythe WR; Vaporciyan AA; Walsh GL; Wu TT; Roth JA
    Ann Thorac Surg; 2004 Oct; 78(4):1152-60; discussion 1152-60. PubMed ID: 15464463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.